Unlock instant, AI-driven research and patent intelligence for your innovation.
Application of radix scutellariae and flavonoid against sub-type infection of influenza virus A (H1N1)
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An anti-influenza virus, baicalin flavonoids technology, applied in antiviral agents, medical preparations containing active ingredients, plant raw materials, etc.
Inactive Publication Date: 2012-11-07
曲敬来
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There is no relevant research or report on the use of baicalin flavones for anti-influenza A new H1N1, influenza A H1N1 and influenza A H3N2
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0034] The assay of embodiment 1 tested sample
[0035] Test sample: baicalein
[0036] Baicalin
[0037] Scutellaria baicalensis total flavonoids extract 1
[0038] Scutellaria baicalensis total flavonoids extract 2
[0039] Determination method: take appropriate amount of four groups of test samples, weigh them accurately, add methanol to dissolve and dilute to a solution with a concentration of 1.0 μg / mL, filter, take the subsequent filtrate as the test solution; take baicalein, baicalin An appropriate amount of glycoside reference substance was prepared in the same way as a corresponding reference substance solution; the contrast solution and the test solution were measured respectively, and determined according to the HPLC method. The elution gradient is shown in the table below, the flow rate is 1mL / min, the injection volume is 20μL, the detection wavelength is 275nm, and the detection is at room temperature.
[0040] The contents of baicalein and baicalin were calcu...
Embodiment 2
[0044] Example 2 The inhibitory effect of baicalein on influenza A subtype
[0045] According to the in vitro antiviral test method under the content of the invention, the inhibitory effect of baicalein test samples on cytopathic changes caused by influenza A H1N1 and H3N2 subtypes was investigated according to the law, and the results of the investigation are shown in the following table:
[0046] Table 2: Inhibitory effect of baicalein on influenza A H1N1 and H3N2 subtypes
[0047]
Embodiment 3
[0048] Embodiment 3: the inhibitory effect of baicalin on influenza A subtype
[0049] According to the in vitro antiviral test method, the inhibitory effect of baicalin test samples on cytopathic changes caused by influenza A H1N1 and H3N2 subtypes was investigated according to law, and the results of the investigation are shown in the following table:
[0050] Table 3: Inhibitory effect of baicalin on influenza A H1N1 and H3N2 subtype viruses
[0051]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses the application of radix scutellariae and flavonoid against sub-type infection of influenza virus A (H1N1), and the application of scutellarein, baicalin and total flavonoid extract of radix scutellaria in preparation of drug against novel influenza A (H1N1), influenza A (H1N1) and H3N2 sub-type of influenza virus and hygienic products. The active substances in the scutellarein, baicalin and total flavonoid extract of radix scutellaria are mixed with an excipient acceptable on pharmaceutics to prepare the preparation and the hygienic products acceptable to patients. The invention is applied to the treatment and the prevention of the novel influenza A (H1N1), influenza A (H1N1) and H3N2 sub-type influenza and has remarkable curative effect and good safety.
Description
technical field [0001] The invention relates to a kind of active substance of baicalin flavonoids which can be used for resisting the subtype infection of influenza A virus, belongs to the technical field of biomedicine, and in particular relates to mixing the active substance of flavonoids with excipients allowed in pharmacy to prepare Patient-acceptable preparations and hygienic articles for the treatment or prevention of new type A H1N1 influenza, type A H1N1 influenza and type A H3N2 influenza. Background technique [0002] Influenza viruses are divided into three types: A, B, and C. The pathogenic strains are mainly types A and B, and type C is basically not pathogenic. Among them, influenza A virus is the main pathogen of several worldwide influenza epidemics, and most of the current epidemics in the world are type A. So far, 15 different hemagglutinins and neuraminidases of influenza A virus have been isolated and identified, which can be divided into various subtype...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More